NFE2L2 and neoplasm: Moreover, GCLM in the Nrf2 pathway enhances the biosynthesis of GSH, thereby improving tumor cell resistance to ROS, which can affect tumor invasion and resistance to chemotherapy (Lin et al. 2023).